Compare ZLAB & MLCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ZLAB | MLCO |
|---|---|---|
| Founded | 2013 | 2003 |
| Country | China | Hong Kong |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Hotels/Resorts |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.6B | 2.2B |
| IPO Year | 2017 | 2006 |
| Metric | ZLAB | MLCO |
|---|---|---|
| Price | $26.25 | $5.19 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 5 |
| Target Price | ★ $49.60 | $10.10 |
| AVG Volume (30 Days) | 1.2M | ★ 1.4M |
| Earning Date | 05-07-2026 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 38.46 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $460,156,000.00 | N/A |
| Revenue This Year | $9.75 | $5.42 |
| Revenue Next Year | $26.03 | $4.37 |
| P/E Ratio | ★ N/A | $12.16 |
| Revenue Growth | ★ 15.33 | N/A |
| 52 Week Low | $15.96 | $4.99 |
| 52 Week High | $34.72 | $9.98 |
| Indicator | ZLAB | MLCO |
|---|---|---|
| Relative Strength Index (RSI) | 60.90 | 42.16 |
| Support Level | $16.98 | $5.13 |
| Resistance Level | $27.08 | $5.73 |
| Average True Range (ATR) | 0.84 | 0.15 |
| MACD | -0.19 | -0.02 |
| Stochastic Oscillator | 53.72 | 35.19 |
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. Zai Lab has a diverse pipeline of potentially first-in-class product candidates developed through in-house R&D and global partnerships. The company has successfully commercialized several products in China, including Zejula, Optune, Qinlock, and Nuzyra, with plans for further expansion The pipeline of proprietary drug candidates of the company includes ZL-1222, ZL-1311, ZL-6201 and many others.
Melco Resorts & Entertainment is one of only six licensed casino operators in Macao. It operates Altira, a complex focused on premium customers; City of Dreams, an integrated resort in Cotai serving both mass-market and premium patrons; and Mocha Clubs' electronic gaming machines. The company also has a majority interest in Studio City, which opened in 2015. Outside Macao, Melco owns City of Dreams Manila in the Philippines and City of Dreams Mediterranean in Cyprus. The business mix in terms of adjusted EBITDA was about 84% from Macao, with the rest from overseas as of 2025.